|
PALX Palomino Laboratories Inc 1938569 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,243,430.00 |
| Balance Sheet |
|
Current Assets
|
$6,825,501.00 |
|
Assets
|
$7,361,705.00 |
|
Current Liabilities
|
$228,862.00 |
|
Liabilities
|
$351,970.00 |
|
Equity
|
$7,009,735.00 |
|
Shares Out
|
18920686.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,116,468.00 |
|
Investing Cash Flow
|
$-318,336.00 |
| Market Analysis |
Market Cap
|
$243,130,815.10 |
|
Price
|
$12.95 |
|
BVPS
|
0.37 |
|
PB
|
34.73 |
|
EPS
|
-0.07 |
|
FCF
|
$-1,434,804.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:02 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PALX documents filed with the SEC.
PALX Filings
Clear
